MBTPS1 and autoimmune disease: In summary, we were able to further elucidate the underlying molecular principles of human T and B cell migration towards the chemoattractant S1P and confirm the effectiveness and mode of action of the novel S1P1 receptor modulator cenerimod in this biological context, taking one more step in tackling the treatment of autoimmune diseases.